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Abstract: Frailty is a geriatric syndrome that refers to a state of reduced resiliency to stressful events
that occurs in response to physiological and/or psychosocial detriments. Frailty is a predictor of
poor prognosis, given that frail older adults are at higher risk of many adverse health-related events.
Hence, the identification of potential strategies to prevent the development and progression of frailty
is of extreme importance for avoiding its negative outcomes. An adequate protein consumption is
advocated as a possible intervention for the management of frailty in older adults due to its effects
on muscle mass and physical function. However, empirical evidence is still needed to support
this proposition. On the other hand, substantial evidence from observational studies has provided
important information on the association between frailty and dietary protein-related parameters.
Here, we provide a narrative review of the current literature regarding the association between
protein intake (amount (how much?), quality (what type?), and distribution across meals (when?))
and frailty-related parameters. The ultimate aim of this work is to offer practical, evidence-based
indications to healthcare professionals responsible for the care of frail older adults.
Keywords: aging; diet; physical function; disability; sarcopenia; nutrition; amino acids; metabolism;
dietary patterns; protein per meal
1. Introduction
Frailty refers to a state of reduced resiliency to stressful events that occur as a consequence
of multisystem derangements and poor social support [1–4]. This condition is highly prevalent in
older adults, especially among hospitalized and institutionalized people, in particular in low- and
middle-income regions [5]. As frailty progresses, people become increasingly more vulnerable to
numerous adverse health-related events, including falls and fractures, cognitive decline, disability,
hospitalization, nursing home placement, and death [6–12]. Hence, the identification of potential
strategies to prevent the development and progression of frailty is of the utmost importance for
avoiding its negative outcomes.
A high dietary protein intake is recognized as a possible intervention for the management of frailty
in older adults due to its effects on muscle mass and physical function [2,13]. Yet, randomized clinical
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trials in support of high protein ingestion are scanty [2,14]. On the other hand, substantial evidence
from observational studies has provided important information on the association between frailty and
dietary protein-related parameters.
Here, we provide an overview of the current literature regarding the association between dietary
protein intake and frailty in older adults. In particular, we describe the influence of the amount
(how much?), quality (what type?), and distribution of dietary protein across meals (when?) on frailty
and frailty-related parameters. The ultimate aim of this work is to provide practical, evidence-based
indications to healthcare professionals responsible for the care of frail older adults.
2. Proteins
Protein composition, absorption, and degradation are a large topic that has been a field of
research for many scientists around the world. This subject is predominately discussed in classes for
nutritionists and endocrinologists and, most of the times, poorly debated in the training of other health
professionals. However, such knowledge has become essential due to the impact of protein intake on
health-related parameters in older adults. Hence, a basic knowledge of the processes associated with
protein metabolism and amino acids (AAs) availability is necessary to understand the main topics of
the present review and discuss them in an interdisciplinary team. Hence, a short introduction to this
theme is provided in the following paragraphs.
Proteins are macromolecules with a pivotal role in many physiological processes involved in body
homeostasis, including structure, function, synthesis, restoration, and transportation. Although the
other macronutrients—carbohydrates and fat—may be stored in the body to be used in situations of
need, protein cannot be deposited into an inactive compound (e.g., glycogen) to serve as a reservoir.
Consequently, dietary protein consumption must be equivalent to bodily metabolic demands to prevent
the use of skeletal muscle contractile proteins as sources of AAs in situations of stress and fasting.
Hence, an adequate supply of dietary proteins is crucial to maintain body homeostasis and function.
Indeed, essential AAs (EAAs) are not produced by the human body and must be acquired
through their extraction from dietary protein (e.g., eggs, milk, cheese). The degradation of protein
into small molecules also differs from the metabolism of other macronutrients by beginning in the
stomach. This process is called proteolysis and has the direct participation of hydrochloric acid
(HCl), which contributes to the proteolytic action of digestive enzymes by revealing peptide bonds.
These peptide bonds are cleaved into smaller AA molecule chains by pepsin, an enzyme activated
by the action of HCl. In the duodenum, trypsin, chymotrypsin, elastase, and carboxypolipeptidase,
enzymes produced in the exocrine part of the pancreas, support the degradation process by cleaving
AA chains into tripeptides and dipeptides. Although tripeptides and dipeptides are smaller than the
AA chains found in the stomach, they still need to be converted into a small and simple molecule of
AA in order to then be absorbed into the bloodstream and transported to target tissues. A schematic
representation of protein absorption and digestion is depicted in Figure 1.
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Figure 1. Protein absorption and digestion. Abbreviations: AA, amino acid; HCl, hydrochloric acid; 
P, protein. 
3. Age-Related Muscle Atrophy, Sarcopenia, and Frailty 
The skeletal muscle is the largest organ of the human body and constitutes almost 50% of the 
total body mass. The muscle is not only the mechanical apparatus of locomotion but represents the 
largest protein “emergency” reservoir in the body and has a pivotal role in the regulation of energy 
metabolism [15]. Recently, its importance as an active endocrine organ that synthesizes and releases 
numerous molecules, collectively called myokines, has been widely acknowledged [16]. 
Muscle mass is regulated by the dynamic and transient equilibrium between muscle protein 
synthesis (MPS) and muscle protein breakdown (MPB) so that it remains virtually unvaried when 
the net balance is zero. Food intake, mainly protein ingestion, is a major regulator of muscle protein 
metabolism [13,17–20]. The increased AA availability stimulates myofibrillar and sarcoplasmic MPS 
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3. Age-Related Muscle Atrophy, Sarcopenia, and Frailty
The skeletal muscle is the largest organ of the human body and constitutes almost 50% of the
total body mass. The muscle is not only the mechanical apparatus of locomotion but represents the
largest protein “emergency” reservoir in the body and has a pivotal role in the regulation of energy
metabolism [15]. Recently, its importance as an active endocrine organ that synthesizes and releases
numerous molecules, collectively called myokines, has been widely acknowledged [16].
Muscle mass is regulated by the dynamic and transient equilibrium between muscle protein
synthesis (MPS) and muscle protein breakdown (MPB) so that it remains virtually unvaried when
the net balance is zero. Food intake, mainly protein ingestion, is a major regulator of muscle protein
metabolism [13,17–20]. The increased AA availability stimulates myofibrillar and sarcoplasmic
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MPS [13,17–20] through the activation of ribosomal protein kinase S6 (S6K1) and 4E-binding protein 1
(4EBP1), under the coordination of the mammalian target of rapamycin (mTOR) [17,20,21].
Notably, the old muscle requires greater amounts of AAs to stimulate muscle anabolism due
to a reduced MPS in response to hyperaminoacidemia [22–25], a phenomenon known as anabolic
resistance (Figure 2). According to Moore et al. [26], up to 140% higher protein intake might be required
by older adults in comparison to young people to maximally stimulate postprandial rates of MPS.
Such a reduced capacity of the old muscle to trigger protein synthesis is reflected by a markedly lower
activation of anabolic signaling pathways, such as mTOR and S6K1, after infusion of EAAs [27]. If the
anabolic resistance is not overcome by a proportionally higher protein intake, reductions in MPS are
expected, causing an imbalance in muscle metabolism that favors MPB and atrophy [28].
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Age-related muscle wasting has important clinical implications due to its close relationship with
declining physical function. Although impaired physical performance in older adults is not fully
explained by muscle atrophy [29], the loss of muscle mass during aging preferably affects type II
fibers [30–32]. These fibers have greater content and higher activity of myosin ATPase and glycolytic
enzymes in comparison to type I muscle fibers [33], which allows them to produce maximal strength
and power and influence mobility [34,35].
Muscle atrophy is also a cardinal element in the development of sarcopenia, also called muscle
failure [36], a degenerative neuromuscular disease that involves significant muscle atrophy, loss of
muscle strength, and physical dysfunction [37]. Sarcopenia is recognized as a major public health
problem, given its association with an increased risk for disability, institutionalization, and death [38,39],
with high prevalence in older adults [40–42] and in people with premature aging [43]. Moreover,
sarcopenia is associated with high healthcare costs (e.g., hospitalization, nursing home admissions),
representing $18.5 billion for the United States Government in 2000 [44].
The progression of sarcopenia may also open the door to the development of other conditions,
such as frailty [45]. Frailty is a geriatric syndrome characterized by a reduced capacity of the
human body to cope with stressful conditions, which occurs in response to a nonlinear multisystem
physiological dysregulation and poor psychosocial support [1–4]. Frailty might occur in adults but is
highly prevalent in the older population [5]. As frailty evolves, people become more vulnerable to many
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negative outcomes [1–4]. Although the theoretical construct of frailty and its clinical importance have
been well established, its operationalization is still hampered by the absence of a univocal definition.
In fact, many instruments for the identification of frailty are available, with limited concordance across
them [46,47].
The phenotypic model proposed by Fried et al. [48] is the most used operational definition of
frailty in research and clinical practice [3,4]. This model was developed by examining more than
5000 participants from the Cardiovascular Health Study (CHS). The frailty phenotype was created based
on five cardinal features: (a) unintentional weight loss; (b) muscle weakness; (c) self-reported fatigue;
(d) impaired mobility, and (e) sedentary behavior. Researchers established that people with three or
more factors should be identified as frail, while those with one or two features should be considered
pre-frail. Researchers also observed that being frail according to their classification was associated with
an increased risk of physical dysfunction, disability, hospitalization, and death [48]. These findings
were expanded by numerous studies [6,7,11,49–52], such that it is currently recognized that frailty
is also associated with cardiovascular abnormalities, depressive symptoms, cognitive dysfunction,
fractures, and nursing home placement.
Notably, sarcopenia and frailty share many clinical features [45], including loss of muscle strength,
physical dysfunction, and body shrinking [53]. Besides these, exhaustion and reductions in physical
activity levels commonly occur with the progression of sarcopenia (Figure 3). Hence, experts in the
field have suggested that sarcopenia might be seen as a precursor for the development of frailty [45].
In other words, frailty may be the product of sarcopenia progression [45]. This idea is further supported
by the higher prevalence of sarcopenia in pre-frail and frail older adults when compared with robust
people [54,55].
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4. How Much? Current Recommendations and Available Evidence
The Estimated Average Requirement (EAR) and the Recommended Dietary Allowances (RDA) are
two reference parameters proposed by the National Academies of Sciences, Engineering, and Medicine
(NASEM) that can be used for planning and assessing diets [56]. EAR refers to the average daily intake
that is sufficient to meet the nutrient requirement of half of the healthy individuals, while the RDA is
thought to be sufficient to meet the nutrient requirement of almost all healthy individuals according to
age and gender. The current EAR and RDA for protein intake are 0.6 g/kg body weight (BW)/day and
0.8 g/kg BW/day, respectively.
However, the value of RDA is debated [13,57–61] since its establishment was based on nitrogen
balance studies. Besides, RDA does not offer specific recommendations for older adults, who seem to
need higher intakes of protein to maintain metabolic homeostasis. The nitrogen balance method is
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based on the fact that proteins are fundamentally composed of nitrogen, which, after being metabolized
through transamination and deamination reactions, is mainly excreted in the urine and, in smaller
quantities, in the feces and skin [56]. According to this paradigm, when nitrogen intake exceeds its
losses, a positive balance is achieved, which favors MPS [56]. On the other hand, a greater excretion of
nitrogen defines a condition of negative nitrogen balance, which is assumed as a catabolic state [56].
The main criticisms to this method are related to (a) slow rate of urea turnover in adults,
which requires several days to adapt to changing levels of protein intake; (b) the apparent retention of
nitrogen by adults, increasing the risk of type I error; (c) the need to include dermal losses of nitrogen
in the final calculation; (d) the accuracy and attention required to perform the evaluation [56].
Besides, empirical evidence using short-term balance approaches (5–10 days) indicates that diets
based on the current RDA for protein intake are insufficient to maintain the nitrogen balance [62,63].
Gersovitz et al. [63] observed that men and women who consumed 0.8 g/kg BW/day of egg protein
were in negative nitrogen balance. Campbell et al. [62] expanded this finding by indicating that
at least 1.0 g/kg BW/day of protein would be necessary to match protein requirements for positive
nitrogen balance.
Taken together, these findings suggest that the current protein RDA might be insufficient to
prevent muscle atrophy in older adults, contributing to the development of sarcopenia and frailty.
Hence, opinion articles and consensus statements have argued that of a dietary protein greater than
the RDA (1.0–1.5 g/kg BW/day) should be recommended to prevent or postpone age-related muscle
atrophy [64–66] and neuromuscular decline [57–61,67]. These premises are based on several studies
in which older adults who reported protein intake higher than the RDA showed better physical
function [68–73].
Such associations between protein intake and sarcopenia-related parameters led researchers to
propose that a high protein diet could also affect frailty status in older adults. Many observational
have confirmed this hypothesis by reporting an inverse association between protein consumption and
frailty status in older adults.
Nanri et al. [74] reported that protein intake was inversely associated with frailty prevalence
in Japanese men and women. Rahi et al. [75] found that high protein intake (≥1.0 g/kg BW/day)
was associated with 59% lower frailty prevalence, after adjustment for covariates, in French old
community-dwellers. Sandoval-Insausti et al. [76] analyzed data of the Seniors-ENRICA (Study on
Nutrition and Cardiovascular Risk Factors in Spain) cohort study in community-dwelling older adults
(≥60 years) and reported increasing odds ratios of frailty for reduced protein intake levels. The authors
observed that the prevalence of frailty was lower in older adults with an average protein intake of
1.28 g/kg BW/day. Beasley et al. [77] provided longitudinal evidence by investigating 24,417 women of
the Women’s Health Initiative Observational Study (WHI-OS). Researchers reported that a protein
consumption of 1.2 g/kg BW/day was associated with a lower risk of incident frailty over three years of
follow-up. These findings are supported by a systematic review and meta-analysis that included more
than 18,000 community-dwelling older adults from five different countries [78].
Although these findings support the need for increasing protein intake in older adults to
avoid frailty, data should be carefully interpreted in light of some important considerations [78].
The main limitation is that the relationship between protein intake and frailty is not unanimous among
studies [74,79,80], and some authors [79] have suggested that protein distribution over the day and/or
protein quality, an index of the amount of EAAs that is provided by a given quantity of protein [81],
may be more relevant to muscle anabolism than overall protein intake. Moreover, these studies used
different instruments for assessing frailty, which might indicate that they captured different frailty
domains [82].
5. What Type? Animal-Based vs. Plant-Based Protein
Protein quality refers to the anabolic response induced by a specific protein source, which can be
of animal (e.g., milk, eggs, meat) or vegetal (e.g., soy, wheat) origin [83]. Protein quality has become a
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trending topic in the field of nutrition and aging, given that plant-based diets (e.g., vegetarian) have
gained considerable popularity [84] and researchers have argued that this type of diet may be more
sustainable by causing lower environmental impact than animal-based diets [83,85]. However, a major
concern with this approach resides in the fact that plant-based protein elicits lower MPS in comparison
to protein from animal sources [19] (Figure 4).
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higher content of branched-chain amino acids (BCAAs), thereby evoking greater stimulation of anabolic
pathways and muscle protein synthesis than plant-based protein.
Anthony et al. [86] reported that whey protein (WP) caused significantly higher phosphorylation
of molecules with a key role in MPS, including mTOR, eIFE, 4E-BP1, and S6K1, than soy protein (SP)
in rats. Mitchell et al. [87] confirmed and expanded these findings by indicating that WP elicited
longer phosphorylation of the ribosomal protein S6K1 in comparison to SP in humans. Moreover,
Tang et al. [19] observed that acute intake of a WP hydrolysate induced greater MPS than soy
consumption in healthy adults. In older people, Yang et al. [88] reported that neither 20 g nor 40 g
of SP stimulated MPS under resting conditions, while myofibrillar MPS was significantly increased
after ingestion of the same doses of WP. Researchers also reported greater MPS after resistance exercise
combined with WP compared with SP plus physical exercise.
The different anabolic responses elicited by animal- and plant-based protein may be attributed
to (a) digestion and absorption kinetics and (b) EAA content, mainly branched-chain amino acids
(BCAAs; i.e., isoleucine, leucine, and valine). Digestibility rates, i.e., the proportion of dietary
protein-derived AAs that is effectively digested and absorbed, becoming available in a form suitable
for body protein synthesis, are significantly different between animal and plant protein sources [83,85].
Indeed, digestibility rates higher than 90% are expected with animal-based protein [83,85]. On the
other hand, less than 50% of digestibility is commonly observed with plant-based protein [83,85].
A possible explanation for this observation may be the fact that plant proteins, mainly soy,
are rapidly digested, causing a marked increase in the transportation of AAs to the liver [89]. Most of
this AA pool undergoes transamination and oxidative deamination reactions to produce ammonia
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and urea, dramatically reducing AA availability for MPS [89]. Unfortunately, only a few studies have
investigated AA kinetics according to protein sources due to the high cost associated with the use of
intrinsically labeled protein sources and further studies are needed in order to better delineate this
phenomenon [90].
Animal-derived protein (e.g., meat, eggs) is believed to have a higher content of EAAs and
BCAAs, thereby evoking greater MPS than plant-based protein (e.g., soya, beans, nuts) [13,83]. Hence,
animal foods are recognized as the primary source of high-quality protein [64,91,92]. EAAs play a key
role in the anabolic response elicited by feeding [93,94], given that the administration of non-EAAs does
not stimulate MPS, whereas muscle anabolism rates near to 90% are observed after EAA infusion [94].
Among EAAs, much attention has been paid to BCAA intake, mainly leucine (reviewed in [95]).
Leucine is considered to be a major stimulator of muscle anabolism [21,96,97]. Acute oral
administration of leucine increased protein synthesis in a dose-dependent way in myoblasts [96] and
in the rat muscle [96,97]. Similar findings have been reported in humans. Rieu et al. [98] observed that
leucine supplementation acutely increased MPS in older adults. Moreover, Atherton et al. [99] found
that leucine administration elicited greater muscle anabolic responses after exercise in young and old
adults compared with participants supplemented with alanine.
The effects of leucine on muscle plasticity are mediated by its actions on the main anabolic
pathways regulating protein synthesis in skeletal muscle [96,97,100]. In fact, leucine stimulates
mTOR [100] and p70 [96,100]. Downstream proteins of the mTOR pathway, including 4E-BP1, eIF4E,
and S6K1, are also phosphorylated in response to leucine bioavailability [96,97,100]. On the other hand,
these anabolic effects were abolished by rapamycin, an inhibitor of mTOR [100].
Although there is no consensus on which of the two factors (digestion and absorption kinetics
or EAA content) is more relevant to muscle anabolism, Wilkinson et al. [101] provided interesting
results for this discussion by comparing the effects of nonfat milk and isonitrogenous SP with similar
amounts of EAAs. Based on their findings, the authors concluded that milk protein promoted greater
and more sustained MPS than soy, suggesting a key role for protein digestion rates in subsequent
anabolic responses [101]
Results from epidemiological studies on the relationship between animal versus plant protein
intake and sarcopenia-related parameters are inconsistent. Muscle mass has been investigated as the
primary outcome of interest in many studies. Animal and plant protein intakes were significantly
associated with muscle mass in middle-aged and older adults [91]. A case-control study found greater
muscle mass in omnivores compared with vegetarian women [102]. Further analyses indicated that
animal, but not vegetal protein intake was significantly associated with muscle mass index, regardless of
dietary patterns [102]. Similarly, Gingrich et al. [66] observed that women with low skeletal muscle
index (SMI) consumed more plant protein and less animal protein than those with normal SMI. Finally,
Alexandrov et al. [103] found a significant association between animal protein consumption and muscle
mass in 31,278 men and 45,355 women from the Lifelines Cohort.
Few longitudinal studies have assessed the association between protein quality and changes
in muscle mass over time. Findings from the Health, Aging, and Body Composition (Health ABC)
study [65] indicated that absolute and animal protein intake were significantly associated with changes
in muscle mass in community-dwelling adults, while no significant associations were observed with
vegetal protein. However, Chan et al. [64] reported that total and animal protein intakes were not
associated with changes in physical performance and appendicular skeletal muscle (ASM) over a 4-year
follow-up in Chinese community-dwelling older adults. However, people who had a relative vegetal
protein consumption higher than 0.72 g/kg BW/day lost significantly less ASM during the follow-up.
Regarding physical performance, Coelho-Junior et al. [92] reported that fast-paced walking speed
was inversely associated with relative animal protein consumption and positively correlated with
the intake of plant-based protein in Brazilian older adults. In contrast, a higher dietary intake of
animal protein was associated with reduced loss of handgrip strength over six years in a cohort of the
Framingham study [104].
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Discrepancies among studies may reflect different designs, population characteristics (e.g.,
age, setting, ethnicity), inclusion of covariates (e.g., physical activity levels), methods for muscle
mass assessment (e.g., bioimpedance, dual-energy X-ray absorptiometry [DEXA]), physical function
parameters considered, and diet assessment methods (e.g., food frequency questionnaires, 24-h recall).
A question that remains unanswered is whether protein sources are associated with frailty in
older adults. Unfortunately, this topic has only recently gained interest. The associations between
animal protein and sarcopenia-related parameters support the idea that this protein source should be
prioritized in older adults. Results from the Seniors-ENRICA study [76] are in line with this perspective
by demonstrating that higher animal protein intake reduced the risk of frailty in community-dwelling
older adults. However, findings from the Health ABC study suggested that a 10-g lower vegetable
protein intake was associated with a 20% higher incidence of pre-frailty or frailty over four years,
while no significant associations were observed with animal protein [105]. Furthermore, animal protein
was only associated with incident physical inactivity, while the occurrence of slowness, weight loss,
and physical inactivity was significantly associated with vegetal protein.
A possible explanation for these findings may reside in the fact that participants of the Health
ABC study showed a higher intake of vegetal protein than those of the ENRICA study, suggesting that
the co-ingestion of protein from foods such as soy, bean, and nuts could provide the quantity of EAAs,
BCAAs, and leucine requested for stimulating muscle anabolism, reducing the risk of sarcopenia and,
thus, frailty [92,105].
An important aspect to be considered in practice is that several factors may impact the consumption
of animal-based protein in older adults, such as oral health, price, and even lifestyle. Cultural and
regional values are also associated with dietary patterns [106–108] and may negatively influence
the adherence to dietary recommendations [109] as well as health-related outcomes [110]. In fact,
our group [111] recently compared dietary habits between Brazilian and Italian older women and
found a higher vegetal protein intake in the former, while animal protein consumption was higher
in Italians.
Meals rich in legumes and vegetables are commonly consumed by Brazilians [112,113] and can
explain the higher intake of plant-based protein observed in this population. Notably, this pattern of
diet is also highly consumed in many Asian (e.g., Thailand, Korea), African (e.g., Zimbabwe, Namibia),
and South American countries (e.g., Paraguay, Chile) [114]. These dietary habits may be linked to the
great symbolic value attributed to meat in low-income countries due to the remnants of monarchy
and slavery [115]. In wealthy countries, the preference toward plant and animal protein might change
according to the geographic region [106]. In Southern Italy, for example, people are more adherent
to the Mediterranean diet, characterized by high consumption of vegetables, fruit, legumes, nuts,
and unprocessed cereals and moderate consumption of fish, eggs, and wine, than people from the
north [106].
Overall, these findings indicate that protein recommendations for counteracting frailty should
consider the importance and impact of cultural values to foster adherence to healthier eating habits.
6. When? Protein Distribution across Meals
Older adults are required to consume larger amounts of protein to maintain muscle anabolism and
avoid negative health-related outcomes. However, achieving such requirements is a major challenge for
frail older people, also given the high prevalence of oral health problems (e.g., chewing and swallowing
difficulties) observed in this population [79].
A possible approach to meet such requirements could be to provide a high protein meal,
pulse-feeding, which is thought to saturate the splanchnic sequestration leading to higher availability
of AAs for MPS [73]. However, studies found that MPS reached a plateau at ~30 g of protein intake
per meal [116,117], after which there was a marked stimulation of whole-body AA oxidation [116].
According to Symons et al. [117], meals providing large amounts of protein (e.g., 90 g) have no greater
effects on MPS than moderate meal servings (e.g., ~30 g of protein).
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Hence, researchers suggested that a spread feeding pattern with at least 30 g of dietary protein
during the main meals (i.e., breakfast, lunch, and dinner) could be a more effective strategy to
counteract age-related muscle atrophy and strength loss in older adults than a pulse-feeding approach,
besides being a more feasible method to provide the amount of recommended protein.
Ten Haaf et al. [73] observed that total protein intake was not associated with either handgrip
strength or Short-Physical Performance Battery (SPPB) scores, while a more spread protein distribution
in the main meals (19–26 g per meal) was related to faster WS in community-dwelling older adults.
These findings were expanded by Loenneke et al. [118] who reported that consuming two or more meals
with 30 g of protein each was associated with greater muscle strength and muscle mass in older adults
compared with the consumption of one or no meal with at least 30 g of protein. Along similar lines,
the consumption of two or three meals per day with adequate protein content (≥30 g) was associated
with a lower risk of physical disability in Mexican older adults without functional limitations [119].
Findings from longitudinal studies are controversial, given that a spread protein intake was associated
with greater muscle mass and strength but not better mobility over two years of follow-up [120,121].
Only one study investigated frail older adults. Bollwein et al. [79] did not observe a significant
association between frailty status and absolute protein intake in community-dwelling older adults.
However, the authors reported that pulse-feeding protein intake, with lower protein consumption at
breakfast and higher intake at lunch, was more frequently observed in pre-frail and frail people.
7. Future Perspectives
The knowledge of the relationship between protein intake and frailty is growing constantly
and substantial evidence has accumulated in the last few years. However, there is still a need for
more information beyond the simplistic view of the amount of required protein. In fact, only a few
cross-sectional studies investigated the association between protein quality and distribution across meals
with frailty prevalence, limiting inferences to clinical practice. In addition, the absence of follow-up
studies does not allow for conclusions to be drawn regarding possible cause-effect relationships.
Another important limitation is the lack of studies that included the assessment of several dietary
protein-related parameters in the same investigation, which could provide a more comprehensive
appraisal of this relationship and, consequently, the generation of more specific guidelines. Similarly,
few studies have taken into consideration the influence of sociodemographic variables on the
quality of dietary protein. Future reviews are required to assess the current state of the art about
ethnic-specific disparities in protein consumption and which variables still need to be better investigated.
This information might have a key role to foster the adherence to nutritional recommendations.
Notably, a recent systematic review and meta-analysis indicated that different instruments had
been used for assessing frailty [82]. This topic deserves attention, given that negative health-related
events (e.g., disability and hospitalization) are differentially predicted by various frailty instruments.
A recent study by our group [122] tried to overcome these limitations by investigating the associations
between frailty status according to three different frailty assessment tools and (a) daily protein intake,
(b) daily BW-adjusted protein intake, (c) BCAA consumption, (d) evenness of protein distribution across
main meals, and (e) number of daily meals providing at least 30 g of protein in community-dwelling
older adults. The assessment tools used were the Fried’s frailty phenotype, the FRAIL scale, and the
Study of Osteoporotic Fracture (SOF) index, which differ in the method used to assess physical function.
We observed a frailty instrument-dependent relationship between frailty status and protein-related
dietary parameters, reflected by the fact that protein consumption and BCAA intake were associated
with frailty status only in participants identified as frail according to the Fried’s frailty phenotype.
Hence, future studies should focus on the simultaneous assessment of several dietary
protein-related parameters, rather than simply looking at the amount of protein. Studies should also
identify frailty using different instruments (e.g., Fried’s frailty phenotype, SOF, FRAIL) and phenotypes
(e.g., physical and multidimensional).
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Although studies have suggested that a high protein intake might be associated with a low frailty
prevalence, extrapolations should be made carefully, given that specific recommendations are necessary
according to the presence of comorbidities. In people with chronic kidney disease (CKD), for example,
very low (~0.4–6 g/kg BW/day) and low (~0.6–8 g/kg BW/day) protein diets have been associated
with a lower incidence of end-stage renal disease and mortality [123,124], while a high dietary protein
intake (≥8 g/kg/d) is believed to induce glomerular injury [125]. Particularly, abnormalities in kidney
function have been observed in frail older women [126], suggesting that a holistic clinical evaluation
should be conducted before recommending changes in protein intake.
The consumption of other macronutrients should also be taken into consideration when planning
changes in protein intake. Indeed, studies have indicated that increased energy intake mediates the
relationship between protein intake and frailty [127–129]. According to findings from observational
studies [130], older adults under long-term low energy intake are more likely to be frail, regardless of
macronutrient consumption. Besides, researchers [130] have reported that the association between the
intake of macronutrients and frailty-related parameters was no longer significant after adjusting for
energy intake, indicating that energy has a key role in this relationship.
An adequate energy intake is normally reached through the consumption of fat and carbohydrate.
During aging, however, a decline in oral health and the loss of appetite might promote the development
of malnutrition and underweight [127,128,131]. Both underweight and malnutrition are among
the criteria for the diagnosis of frailty [48,132], besides being associated with other frailty-related
parameters, such as physical function impairment and weakness [133], likely promoting a sedentary
behavior [134]. Moreover, a negative energy balance contributes to muscle atrophy and bone loss,
providing a suitable environment for the development of sarcopenia and osteoporosis, respectively,
two diseases closely associated with frailty development and progression [128].
Veganism, covering a variety of diet patterns that involve the avoidance of meat, has gained
increasing popularity and represents a growing social movement [135]. Adherence to a vegan
diet, even if only for short periods (7 weeks), might beneficially affect several cardiovascular
risk factors [136,137], including BW, body mass index, systolic and diastolic blood pressure,
total and high-density cholesterol, and C-reactive protein, as well as ameliorate the quality of
life [137]. Of particular interest are findings that indicate similar exercise capacity among vegan,
lacto-ovo-vegetarian, and omnivorous recreational runners, suggesting that an optimal physical
performance might be reached with different diet patterns. These health benefits may be valuable for
older adults, including frail people, and deserve urgent investigation.
The implementation of innovative, minimally invasive technologies (e.g., novel stable isotope
tracer combined with “virtual biopsy” and deuterated-creatine dilution methods) will help address
issues related to skeletal muscle protein kinetics and muscle mass assessment [138,139]. This will be
instrumental for evaluating the efficacy of nutritional intervention designed to counteract sarcopenia
and frailty [140].
Lastly, heterogeneity in response to specific nutrients and dietary patterns among older adults
may exist [141,142]. The implementation of integrated “omics” approaches may lead to more accurate
dietary assessments [143] and the elaboration and monitoring of personalized dietary plans, tailored to
an individual’s metabolic phenotypes and needs [144]. This information could represent a critical step
to guide future scientific consensus-based, personalized dietary counseling [142].
8. Conclusions
Protein-related parameters are associated with frailty in older adults. Many studies have described
an inverse association between the amount of protein intake and frailty prevalence, leading experts
in the field to suggest that greater amounts of protein than the current RDA (1.0–1.5 g/kg BW/day)
are necessary to prevent frailty. Protein source may also impact the development and progression of
frailty, with animal-based protein believed to provide a higher amount of BCAAs than plant-based
protein, consequently evoking greater anabolic responses. However, plant protein is preferably
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consumed in some countries and studies have supported its positive association with physical function.
Hence, cultural values should be taken into consideration in future guidelines to increase adherence.
Few studies have explored the association between protein distribution across meals and frailty. Most of
them found that the consumption of at least 30 g of protein in two or more meals might be more
effective at preserving muscle mass and physical performance compared with the consumption of
a single high-protein meal. However, the only study of such a kind conducted in frail older adults
provided different results. The optimal distribution of protein across meals is an important topic to be
addressed for the achievement of protein requirements in older adults. Finally, future studies should
use a longitudinal design, combine the assessment of several protein-related parameters, instead of
only the amount of protein intake, and identify frailty using different instruments.
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